Streetbeat News

Products Services

ELAN

Parasites & Vectors published a study showing Elanco's Credelio flea and tick protection product achieves the fastest tick kill in 12 hours and maintains effectiveness throughout the dosing interval. The study highlights the importance of tick protection as the CDC reports over 45,000 human tickborne disease cases between 2019-2022.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:38 pm

BKYI

BIO-Key shares are trading higher following a year-over-year increase in Q2 EPS results and the launch of its PortalGuard IDaaS platform in the AWS marketplace.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:37 pm

CING

Cingulate shares are trading higher after the company was granted European patent No. 3261625 for CTx-1301, its lead asset for the treatment of ADHD.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:32 pm

DJT

Trump Media & Technology Group (NASDAQ:DJT) saw its shares dip and approach record lows following disappointing quarterly results and former President Donald Trump’s return to the social media platform X. The company's stock has been volatile, facing challenges as Trump's lead in polls shrinks and significant spending on a new streaming service raises concerns about its future.

Portfolio Pulse from Anusuya Lahiri

August 15, 2024 | 12:31 pm

SVRA

Savara announced the acceptance of an abstract for a poster presentation at the European Respiratory Society Congress 2024 in Vienna. The company will present results from the IMPALA-2 study on inhaled Molgramostim for autoimmune pulmonary alveolar proteinosis and sponsor an industry symposium.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:23 pm

CNSP

CNS Pharmaceuticals reported a reduced net loss of $2.5M for Q2 2024, attributed to lower CRO expenses. R&D costs decreased to $1.1M, while G&A expenses increased to $1.4M due to higher legal and professional fees. The company has a cash position of $1.5M, with an additional $12.4M raised post-June 30, ensuring sufficient funds through Q1 2025. Final Berubicin trial data is expected in H1 2025.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:18 pm

AAPL

Apple Inc. (NASDAQ:AAPL) and Tencent are in discussions about a potential revenue-sharing agreement for WeChat mini-games. This could enable in-app purchases on iOS, benefiting developers, users, Apple, and Tencent. The move comes as Apple seeks to boost its presence in China amid declining market share.

Portfolio Pulse from Benzinga Neuro

August 15, 2024 | 12:17 pm

HOTH

Hoth Therapeutics has entered into a Master Services Agreement with Aronnax for the development of HT-KIT, a cancer therapeutic. This partnership aims to advance the clinical development of HT-KIT, potentially accelerating its path to market.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:17 pm

TSLA

Tesla's Supercharger network has been ranked highest in customer satisfaction among DC fast charger brands in the U.S. for the fourth consecutive year, according to a JD Power study. Tesla scored 731 points out of 1,000, significantly higher than Electrify America and ChargePoint. The opening of Tesla’s network to non-Tesla EV owners has contributed to the increased satisfaction. However, non-Tesla users face challenges such as the need for adapters and more complex payment processes. Despite the growth in the number of superchargers, the rate has slowed due to layoffs and other issues.

Portfolio Pulse from Anan Ashraf

August 15, 2024 | 12:16 pm

AISP

CING

WMT

On August 15th, Walmart (WMT) raised its FY25 adjusted EPS outlook, Cingulate (CING) received a European patent for its lead asset CTx-1301, and Airship AI Holdings (AISP) reported a year-over-year increase in Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:14 pm